Abstract:Introduction: Chronic obstructive pulmonary disease (COPD), an incurable chronic respiratory disease, has become a major public health problem. The relationship between the composition of intestinal microbiota and the important clinical factors affecting COPD remains unclear. This study aimed to identify specific intestinal microbiota with high clinical diagnostic value for COPD. Methods: The fecal microbiota of patients with COPD and healthy individuals were analyzed by 16S rDNA sequencing. Random forest classification was performed to analyze the different intestinal microbiota. Spearman correlation was conducted to analyze the correlation between different intestinal microbiota and clinical characteristics. A microbiota-disease network diagram was constructed using the gut MDisorder database to identify the possible pathogenesis of intestinal microorganisms affecting COPD, screen for potential treatment, and guide future research. Results: No significant difference in biodiversity was shown between the two groups but significant differences in microbial community structure. Fifteen genera of bacteria with large abundance differences were identified, including Bacteroides, Prevotella, Lachnospira, and Parabacteroides. Among them, the relative abundance of Lachnospira and Coprococcus was negatively related to the smoking index and positively related to lung function results. By contrast, the relative abundance of Parabacteroides was positively correlated with the smoking index and negatively correlated with lung function findings. Random forest classification showed that Lachnospira was the genus most capable of distinguishing between patients with COPD and healthy individuals suggesting it may be a potential biomarker of COPD. A Lachnospira disease network diagram suggested that Lachnospira decreased in some diseases, such as asthma, diabetes mellitus, and coronavirus disease 2019 (COVID-19), and increased in other diseases, such as irritable bowel syndrome, hypertension, and bovine lichen. Conclusion: The dominant intestinal microbiota with significant differences is related to the clinical characteristics of COPD, and the Lachnospira has the potential value to identify COPD.

Cigarette smoke-induced dysbiosis: comparative analysis of lung and intestinal microbiomes in COPD mice and patients

Cigarette Smoking Altered Gut Microbiota in a Mouse Model: the Microbial Lung-Gut Axis

Combined exposure to bacteria and cigarette smoke resembles characteristic phenotypes of human COPD in a murine disease model.

Gut Microbiome and Transcriptomic Changes in Cigarette Smoke-Exposed Mice Compared to COPD and CD Patient Datasets

Mitochondrial Iron Chelation Ameliorates Cigarette Smoke–induced Bronchitis and Emphysema in Mice

Lower Airway Dysbiosis Augments Lung Inflammatory Injury in Mild-to-Moderate COPD

Gut microbiota dysbiosis contributes to the development of chronic obstructive pulmonary disease

Smoking-induced microbial dysbiosis in health and disease

Changes in intestinal homeostasis and immunity in a cigarette smoke- and LPS-induced murine model for COPD: the lung-gut axis

When smoke meets gut: deciphering the interactions between tobacco smoking and gut microbiota in disease development

Smoking and microbiome in oral, airway, gut and some systemic diseases

Microbiome Links Cigarette Smoke-Induced Chronic Obstructive Pulmonary Disease and Dietary Fiber via the Gut-Lung Axis: A Narrative Review

2D cross-omics integrated enrichment analysis reveals insights into COPD pathogenesis

Effect of Cigarette Smoke on Gut Microbiota: State of Knowledge

Faecal microbial transfer and complex carbohydrates mediate protection against COPD

Promising Intestinal Microbiota Associated with Clinical Characteristics of COPD Through Integrated Bioinformatics Analysis

Fecal microbial transfer and complex carbohydrates mediate protection against COPD

Imbalance of Th17/Treg Cells in Mice with Chronic Cigarette Smoke Exposure.

Smoking-related gut microbiota alteration is associated with obesity and obesity-related diseases: results from two independent cohorts with sibling comparison analyses

Chronic cigarette smoke exposure and pneumococcal infection induce oropharyngeal microbiota dysbiosis and contribute to long-lasting lung damage in mice

The sputum microbiome is distinct between COPD and health, independent of smoking history